First Trust Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34M | Buy |
1,232,952
+318,183
| +35% | +$8.78M | 0.03% | 722 |
|
|
2025
Q1 | $25.9M | Buy |
914,769
+246,302
| +37% | +$6.98M | 0.02% | 780 |
|
|
2024
Q4 | $27.8M | Buy |
668,467
+31,645
| +5% | +$1.32M | 0.02% | 737 |
|
|
2024
Q3 | $42.6M | Buy |
636,822
+127,990
| +25% | +$8.55M | 0.04% | 558 |
|
|
2024
Q2 | $60.4M | Sell |
508,832
-95,514
| -16% | -$11.3M | 0.06% | 362 |
|
|
2024
Q1 | $64.4M | Sell |
604,346
-288,970
| -32% | -$30.8M | 0.07% | 386 |
|
|
2023
Q4 | $88.8M | Buy |
893,316
+102,251
| +13% | +$10.2M | 0.1% | 254 |
|
|
2023
Q3 | $81.7M | Buy |
791,065
+39,807
| +5% | +$4.11M | 0.1% | 261 |
|
|
2023
Q2 | $91.3M | Buy |
751,258
+82,476
| +12% | +$10M | 0.1% | 251 |
|
|
2023
Q1 | $103M | Sell |
668,782
-130,909
| -16% | -$20.1M | 0.12% | 222 |
|
|
2022
Q4 | $144M | Buy |
799,691
+172,731
| +28% | +$31M | 0.17% | 164 |
|
|
2022
Q3 | $74.1M | Buy |
626,960
+122,146
| +24% | +$14.4M | 0.1% | 295 |
|
|
2022
Q2 | $72.1M | Sell |
504,814
-2,459
| -0.5% | -$351K | 0.09% | 327 |
|
|
2022
Q1 | $87.4M | Buy |
507,273
+142,297
| +39% | +$24.5M | 0.09% | 297 |
|
|
2021
Q4 | $92.7M | Sell |
364,976
-114,511
| -24% | -$29.1M | 0.09% | 270 |
|
|
2021
Q3 | $185M | Sell |
479,487
-282,557
| -37% | -$109M | 0.2% | 137 |
|
|
2021
Q2 | $179M | Buy |
762,044
+227,063
| +42% | +$53.4M | 0.19% | 134 |
|
|
2021
Q1 | $70.1M | Buy |
534,981
+132,798
| +33% | +$17.4M | 0.08% | 327 |
|
|
2020
Q4 | $42M | Buy |
402,183
+40,468
| +11% | +$4.23M | 0.06% | 454 |
|
|
2020
Q3 | $25.6M | Sell |
361,715
-41,219
| -10% | -$2.92M | 0.04% | 472 |
|
|
2020
Q2 | $25.9M | Sell |
402,934
-36,012
| -8% | -$2.31M | 0.04% | 485 |
|
|
2020
Q1 | $13.1M | Buy |
+438,946
| New | +$13.1M | 0.03% | 577 |
|